Nov 24, 2020 | News, Press Releases
Pilot study explored the application of MDMA-assisted psychotherapy in 18 individuals experiencing moderate to severe anxiety following diagnosis with a life-threatening illness The primary outcome, change in State-Trait Anxiety Inventory (STAI) Trait Scores,...Oct 14, 2020 | News, Press Releases
Healthcare cost savings of MDMA-assisted psychotherapy for PTSD estimated to be greater than $103.2 million with a return of 5,553 Quality of Life Years per 1,000 patients Santa Cruz, CA, October 14, 2020 – A peer-reviewed study published today in the research journal...Jun 10, 2020 | News, Press Releases
MEDIA CONTACT:Brad Burge, Director of Strategic Communications, MAPSbrad@maps.org GENERAL QUESTIONS:AskMAPS@maps.org Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the publication of the long-term follow-up results of six...
